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Comments regarding “The Wonders of New Available Post-Analysis CT Software
in the Hands of Vascular Surgeons”
M.T. Voûte*, F.M. Bastos Gonçalves, H.J.M. Verhagen
Department of Vascular Surgery, Erasmus Medical Center, Vascular Surgery, s-Gravendijkwal 230, 3000 CA Rotterdam, The NetherlandsThe authors of this manuscript present a case where an endo-
leak was detected in a growing aneurysm sac, after endovascular
aneurysm repair. This was presumed to be a type-II EL, and it was
not until reconstructions with open source post-processing soft-
ware were made that they discovered device failure as the origin of
the endoleak.
This case report clearly underlines the added value of
reconstruction software, as it altered the diagnosis from a type II
endoleak e the optimal management of which is still debatable e
to a type III endoleak, which constitutes a serious and threatening
complication requiring expeditious intervention.
Although the value of using post-processing software to
improve insight in the anatomy and to provide more accurate
diameter and lengthmeasurements is undisputable, advocating the
wide use of OsiriX open-source version has some important pitfalls
not highlighted by the authors. First of all, this has not been
approved for primary clinical use to our knowledge. This may pose
serious ethical and medicolegal issues. Fortunately, there are
several commercially available FDA approved alternatives,
including OsiriX MD.1 Second, before adopting reconstruction
software in clinical practice, education in post-processing is
paramount, as deﬁcient use of these tools may result in misleading
information and generate errors in patient management.
Apart from the arguments in favor of reconstruction software,
the clinical case that was presented also provided some food forDOI of original article: 10.1016/j.ejvs.2011.11.027.
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doi:10.1016/j.ejvs.2012.01.011thought. The ﬁnal diagnosis was graft failure as a result of graft
material discontinuity in the main body, although no cause of this
could be traced. This ﬁnding is worrying, especially since the
implantationwas only sixteenmonths before. Mandatory reporting
of graft failures should be part of standard care to improve overall
quality.
Last but not least, this case emphasizes that ﬁnding a type II
endoleak in a patient with a growing aneurysm should never
preclude the search for an alternative, more serious cause for
growth. It is of utmost importance to make sure that growth is not
caused by a type I a/b or III endoleak. Assuring a generous proximal
and distal seal is key in this. Furthermore, contrast-enhanced
magnetic resonance using a blood pool agent can help identifying
the cause of growth as well, as it has demonstrated that many
growing aneurysms without detectable endoleaks on CTA may
actually have occult endoleaks.2 Only if one is convinced that no
other cause than type II endoleak is present, conservative treatment
may be advisable.
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